Advent Pharma Ltd. (DSE:ADVENT)

Advent Pharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	1,341	1,499	1,267	2,384	2,459	2,338
Market Cap Growth	8.27%	18.38%	-46.88%	-3.03%	5.18%	2.82%
Enterprise Value	1,417	1,576	1,338	2,456	2,530	2,392
Last Close Price	14.40	16.10	13.55	25.34	25.90	24.41

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PE Ratio	34.29	38.55	18.94	28.39	24.93	23.97
PS Ratio	3.29	3.73	2.53	4.17	4.41	4.41
PB Ratio	0.84	0.96	0.83	1.62	1.76	1.78
P/TBV Ratio	0.84	0.96	0.83	1.62	1.76	1.78
P/FCF Ratio	612.17	694.08	61.59	182.32	958.68	-
P/OCF Ratio	91.99	104.30	11.04	13.61	11.98	13.02

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
EV/Sales Ratio	3.48	3.92	2.67	4.30	4.53	4.51
EV/EBITDA Ratio	11.38	12.89	8.46	11.83	13.05	13.66
EV/EBIT Ratio	22.36	25.20	13.99	17.34	18.69	17.93
EV/FCF Ratio	647.34	729.61	65.04	187.80	986.61	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Debt / Equity Ratio	0.05	0.05	0.05	0.05	0.05	0.05
Debt / EBITDA Ratio	0.62	0.62	0.48	0.37	0.37	0.36
Debt / FCF Ratio	35.37	35.37	3.69	5.81	27.92	-
Net Debt / Equity Ratio	0.05	0.05	0.05	0.05	0.05	0.05
Net Debt / EBITDA Ratio	0.62	0.62	0.47	0.35	0.36	0.34
Net Debt / FCF Ratio	35.17	35.17	3.60	5.51	27.50	-5.16
Asset Turnover	0.21	0.21	0.26	0.31	0.33	0.34
Inventory Turnover	3.65	3.65	4.87	4.68	4.16	3.96
Quick Ratio	1.36	1.36	1.01	0.78	0.62	0.71
Current Ratio	2.72	2.72	1.51	1.28	1.15	1.38
Return on Equity (ROE)	2.51%	2.51%	4.46%	5.85%	7.27%	7.66%
Return on Assets (ROA)	1.99%	1.99%	3.15%	4.86%	4.93%	5.27%
Return on Invested Capital (ROIC)	2.90%	2.93%	4.71%	7.61%	7.30%	7.61%
Return on Capital Employed (ROCE)	3.50%	3.50%	5.50%	8.50%	8.60%	9.00%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Earnings Yield	2.92%	2.59%	5.28%	3.52%	4.01%	4.17%
FCF Yield	0.16%	0.14%	1.62%	0.55%	0.10%	-0.49%
Dividend Yield	0.35%	-	0.37%	0.39%	0.76%	0.80%
Payout Ratio	4.15%	4.15%	22.06%	9.76%	8.93%	22.79%
Buyback Yield / Dilution	0.28%	0.55%	-	-	-	-
Total Shareholder Return	0.63%	0.55%	0.37%	0.39%	0.76%	0.80%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error